Brain & mental health: new FDA approvals
Brand, generic name, approval date and the use the FDA approved it for. No recommendations. Updated 2026-10-12.
Weight loss & diabetesCancerBrain & mental healthInfections & vaccinesHeart & bloodImmune & inflammatoryKidney, liver & lungEyeWomen's & hormonal healthPain & anesthesiaDiagnostic & imaging agentsRare & geneticOther
JuvmoBrain & mental health
tavapadonTo treat Parkinson’s disease in adultsIsembyldBrain & mental health
apitegromab-mstnTo treat spinal muscular atrophy in adults and pediatric patients 2 years of age and older who are currently receiving an SMN2-targeted treatmentZanvastroBrain & mental health
zilganersenTo treat Alexander disease in pediatric and adult patientsTauklarifyBrain & mental health
florquinitau F 18To be used for positron emission tomography of the brain in adults with cognitive impairment who are being evaluated for Alzheimer disease to identify patients with tau neurofibrillary tangle pathologyBysantiBrain & mental health
milsaperidone · Vanda Pharms Inc.To treat schizophrenia and to treat manic or mixed episodes associated with bipolar I disorderImaavyBrain & mental health
nipocalimab-aahu · Janssen BiotechTo treat generalized myasthenia gravisKisunlaBrain & mental health
donanemab-azbt · Eli Lilly CoTo treat Alzheimer’s disease